169 related articles for article (PubMed ID: 32631662)
1. Acute kidney injury after cytoreductive surgery and hyperthermic intraoperative cisplatin chemotherapy for malignant pleural mesothelioma.
Hod T; Freedberg KJ; Motwani SS; Chen M; Frendl G; Leaf DE; Gupta S; Mothi SS; Richards WG; Bueno R; Waikar SS
J Thorac Cardiovasc Surg; 2021 Apr; 161(4):1510-1518. PubMed ID: 32631662
[TBL] [Abstract][Full Text] [Related]
2. Hyperthermic intraoperative pleural cisplatin chemotherapy extends interval to recurrence and survival among low-risk patients with malignant pleural mesothelioma undergoing surgical macroscopic complete resection.
Sugarbaker DJ; Gill RR; Yeap BY; Wolf AS; DaSilva MC; Baldini EH; Bueno R; Richards WG
J Thorac Cardiovasc Surg; 2013 Apr; 145(4):955-963. PubMed ID: 23434448
[TBL] [Abstract][Full Text] [Related]
3. Interim results of pleurectomy/decortication and intraoperative intrapleural hyperthermic cisplatin perfusion for patients with malignant pleural mesothelioma intolerable to extrapleural pneumonectomy.
Ishibashi H; Kobayashi M; Takasaki C; Okubo K
Gen Thorac Cardiovasc Surg; 2015 Jul; 63(7):395-400. PubMed ID: 25750109
[TBL] [Abstract][Full Text] [Related]
4. Extrapleural pneumonectomy followed by intracavitary intraoperative hyperthermic cisplatin with pharmacologic cytoprotection for treatment of malignant pleural mesothelioma: a phase II prospective study.
Tilleman TR; Richards WG; Zellos L; Johnson BE; Jaklitsch MT; Mueller J; Yeap BY; Mujoomdar AA; Ducko CT; Bueno R; Sugarbaker DJ
J Thorac Cardiovasc Surg; 2009 Aug; 138(2):405-11. PubMed ID: 19619785
[TBL] [Abstract][Full Text] [Related]
5. Return to intended oncologic treatment after surgery for malignant pleural mesothelioma.
Nelson DB; Rice DC; Mitchell KG; Tsao AS; Gomez DR; Sepesi B; Mehran RJ
J Thorac Cardiovasc Surg; 2019 Sep; 158(3):924-929. PubMed ID: 31430846
[TBL] [Abstract][Full Text] [Related]
6. Pleurectomy and decortication are associated with better survival for bicavitary cytoreductive surgery for mesothelioma compared with extrapleural pneumonectomy.
Ripley RT; Holmes HM; Whitlock RS; Groth SS; Medina CG; Choi EA; Burt BM; Sugarbaker PH
J Thorac Cardiovasc Surg; 2023 May; 165(5):1722-1730. PubMed ID: 36740497
[TBL] [Abstract][Full Text] [Related]
7. A phase I study of extrapleural pneumonectomy and intracavitary intraoperative hyperthermic cisplatin with amifostine cytoprotection for malignant pleural mesothelioma.
Zellos L; Richards WG; Capalbo L; Jaklitsch MT; Chirieac LR; Johnson BE; Bueno R; Sugarbaker DJ
J Thorac Cardiovasc Surg; 2009 Feb; 137(2):453-8. PubMed ID: 19185169
[TBL] [Abstract][Full Text] [Related]
8. Cytoreductive surgery and hyperthermic intrathoracic chemotherapy perfusion for malignant pleural tumours: perioperative management and clinical experience.
Ried M; Potzger T; Braune N; Neu R; Zausig Y; Schalke B; Diez C; Hofmann HS
Eur J Cardiothorac Surg; 2013 Apr; 43(4):801-7. PubMed ID: 22885228
[TBL] [Abstract][Full Text] [Related]
9. A Phase I Trial of Surgical Resection and Intraoperative Hyperthermic Cisplatin and Gemcitabine for Pleural Mesothelioma.
Burt BM; Richards WG; Lee HS; Bartel S; Dasilva MC; Gill RR; Jaklitsch MT; Johnson BE; Swanson SJ; Bueno R; Sugarbaker DJ
J Thorac Oncol; 2018 Sep; 13(9):1400-1409. PubMed ID: 29753120
[TBL] [Abstract][Full Text] [Related]
10. Hyperthermic intraoperative intrapleural chemotherapy and surgical cytoreduction as part of multimodal treatment of malignant pleural mesothelioma - case report M. Szkorupa1, D. Klos1, J. Chudacek1, J. Hanuliak1, M. Stasek1, O. Fischer2, R. Lemstrova3.
Chemotherapy HII; Report SCAPOMTOMPM; Szkorupa M; Klos D; Chudacek J; Hanuliak J; Stasek M; Fischer O; Lemstrová R
Rozhl Chir; 2020; 99(10):456-461. PubMed ID: 33242963
[TBL] [Abstract][Full Text] [Related]
11. Cytoreductive surgery and intraoperative hyperthermic intrathoracic chemotherapy in patients with malignant pleural mesothelioma or pleural metastases of thymoma.
de Bree E; van Ruth S; Baas P; Rutgers EJ; van Zandwijk N; Witkamp AJ; Zoetmulder FA
Chest; 2002 Feb; 121(2):480-7. PubMed ID: 11834661
[TBL] [Abstract][Full Text] [Related]
12. Commentary: Cisplatin-induced nephrotoxicity following cytoreductive surgery and heated intraoperative chemotherapy for malignant pleural mesothelioma.
Groth SS; Ripley RT
J Thorac Cardiovasc Surg; 2021 Apr; 161(4):1519-1520. PubMed ID: 32771233
[No Abstract] [Full Text] [Related]
13. Malignant pleural mesothelioma and the Society of Thoracic Surgeons Database: an analysis of surgical morbidity and mortality.
Burt BM; Cameron RB; Mollberg NM; Kosinski AS; Schipper PH; Shrager JB; Vigneswaran WT
J Thorac Cardiovasc Surg; 2014 Jul; 148(1):30-5. PubMed ID: 24726744
[TBL] [Abstract][Full Text] [Related]
14. Pleurectomy/decortication, hyperthermic pleural lavage with povidone-iodine, prophylactic radiotherapy, and systemic chemotherapy in patients with malignant pleural mesothelioma: a 10-year experience.
Lang-Lazdunski L; Bille A; Papa S; Marshall S; Lal R; Galeone C; Landau D; Steele J; Spicer J
J Thorac Cardiovasc Surg; 2015 Feb; 149(2):558-65; discussion 565-6. PubMed ID: 25726878
[TBL] [Abstract][Full Text] [Related]
15. Hyperthermic pleural perfusion with cisplatin: early clinical experience.
Yellin A; Simansky DA; Paley M; Refaely Y
Cancer; 2001 Oct; 92(8):2197-203. PubMed ID: 11596038
[TBL] [Abstract][Full Text] [Related]
16. Pleurectomy/decortication and hyperthermic intrapleural chemotherapy for malignant pleural mesothelioma: initial experience.
Migliore M; Calvo D; Criscione A; Palmucci S; Fuccio Sanzà G; Caltabiano R; Spatola C; Privitera G; Aiello MM; Parra HS; Ciancio N; Di Maria G
Future Oncol; 2015; 11(24 Suppl):19-22. PubMed ID: 26638918
[TBL] [Abstract][Full Text] [Related]
17. Cytoreductive surgery and hyperthermic intrapleural chemotherapy for malignant pleural diseases: preliminary experience.
Migliore M; Calvo D; Criscione A; Viola C; Privitera G; Spatola C; Parra HS; Palmucci S; Ciancio N; Caltabiano R; Di Maria G
Future Oncol; 2015; 11(2 Suppl):47-52. PubMed ID: 25662329
[TBL] [Abstract][Full Text] [Related]
18. Pleurectomy/decortication plus chemotherapy: outcomes of 40 cases of malignant pleural mesothelioma.
Colaut F; Toniolo L; Vicario G; Scapinello A; Visentin C; Manente P; Sartori CA
Chir Ital; 2004; 56(6):781-6. PubMed ID: 15771030
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial.
Stahel RA; Riesterer O; Xyrafas A; Opitz I; Beyeler M; Ochsenbein A; Früh M; Cathomas R; Nackaerts K; Peters S; Mamot C; Zippelius A; Mordasini C; Caspar CB; Eckhardt K; Schmid RA; Aebersold DM; Gautschi O; Nagel W; Töpfer M; Krayenbuehl J; Ribi K; Ciernik IF; Weder W
Lancet Oncol; 2015 Dec; 16(16):1651-8. PubMed ID: 26538423
[TBL] [Abstract][Full Text] [Related]
20. Surgical Cytoreduction and HITOC for Thymic Malignancies with Pleural Dissemination.
Markowiak T; Neu R; Ansari MKA; Großer C; Klinkhammer-Schalke M; Hofmann HS; Ried M
Thorac Cardiovasc Surg; 2021 Mar; 69(2):157-164. PubMed ID: 31731316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
